Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M59,146Revenue $M39,874Net Margin (%)15.0Z-Score2.4
Enterprise Value $M57,731EPS $3.3Operating Margin %20.3F-Score0
P/E(ttm))11.6Cash Flow Per Share $6.7Pre-tax Margin (%)15.7Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %10.3Quick Ratio1.3Cash flow > EarningsN
Price/Sales1.55-y EBITDA Growth Rate %7.6Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %0ROA % (ttm)8.9Higher Current Ratio y-yN
Dividend Yield %3.5Insider Buy (3m)1ROE % (ttm)22.3Less Shares Outstanding y-yN
Payout Ratio %50.5Shares Outstanding M1,571ROI % (ttm)21.4Gross Margin Increase y-yN

Gurus Latest Trades with ABT

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTPRIMECAP Management 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 37.4811%Add 58.55%11,683,747
ABTGeorge Soros 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 37.4811%Add 93.84%1,140,752
ABTMario Gabelli 2013-03-31 Add0.01%$31.34 - $35.32
($33.84)
$ 37.4811%Add 40.97%84,215
ABTDaniel Loeb 2013-03-31 Sold Out -1.1%$31.34 - $35.32
($33.84)
$ 37.4811%Sold Out0
ABTJoel Greenblatt 2013-03-31 Sold Out -0.06%$31.34 - $35.32
($33.84)
$ 37.4811%Sold Out0
ABTMeridian Funds 2013-03-31 Sold Out -0.02%$31.34 - $35.32
($33.84)
$ 37.4811%Sold Out0
ABTMason Hawkins 2012-12-31 Add1.43%$30.09 - $34.51
($31.58)
$ 37.4819%Add 85.61%14,754,193
ABTDaniel Loeb 2012-12-31 Buy 1.1%$30.09 - $34.51
($31.58)
$ 37.4819%New holding, 1834000 sh.1,834,000
ABTGeorge Soros 2012-12-31 Add0.3%$30.09 - $34.51
($31.58)
$ 37.4819%Add 194.25%588,500
ABTPRIMECAP Management 2012-12-31 Add0.27%$30.09 - $34.51
($31.58)
$ 37.4819%Add 61.62%7,369,047
ABTRonald Muhlenkamp 2012-12-31 Sold Out -4.7%$30.09 - $34.51
($31.58)
$ 37.4819%Sold Out0
ABTScott Black 2012-12-31 Sold Out -0.33%$30.09 - $34.51
($31.58)
$ 37.4819%Sold Out0
ABTDonald Yacktman 2012-12-31 Sold Out -0.0012%$30.09 - $34.51
($31.58)
$ 37.4819%Sold Out0
ABTJohn Hussman 2012-09-30 Add0.25%$63.95 - $69.84
($66.33)
$ 37.48-44%Add 42.74%501,000
ABTGeorge Soros 2012-09-30 Buy 0.22%$63.95 - $69.84
($66.33)
$ 37.48-44%New holding, 200000 sh.200,000
ABTJoel Greenblatt 2012-09-30 Add0.03%$63.95 - $69.84
($66.33)
$ 37.48-44%Add 62.83%16,426
ABTDonald Yacktman 2012-09-30 Buy $63.95 - $69.84
($66.33)
$ 37.48-44%New holding, 3000 sh.3,000
ABTRonald Muhlenkamp 2012-09-30 Reduce-1.51%$63.95 - $69.84
($66.33)
$ 37.48-44%Reduce -23.66%326,270
ABTMario Gabelli 2012-09-30 Reduce-0.01%$63.95 - $69.84
($66.33)
$ 37.48-44%Reduce -28.77%54,209
ABTPRIMECAP Management 2012-06-30 Add0.14%$59.49 - $63.4
($61.55)
$ 37.48-39%Add 45.41%4,124,647
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT George Soros 2013-03-311,140,7520.070.47+93.84%
ABT PRIMECAP Management 2013-03-3111,683,7470.740.61+58.55%
ABT Mario Gabelli 2013-03-3184,2150.010.02+40.97%
ABT John Hussman 2013-03-31401,7500.030.52
ABT Dodge & Cox 2013-03-3137,86500-0.39%
ABT Mason Hawkins 2013-03-3114,554,6780.932.3-1.35%
ABT Vanguard Health Care Fund 2013-03-319,347,7000.61.3-7.9%
ABT Meridian Funds 2013-03-31000Sold Out
ABT Joel Greenblatt 2013-03-31000Sold Out
ABT Daniel Loeb 2013-03-31000Sold Out
ABT Scott Black 2012-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Grace, MarkSenior Officer 2013-02-20Sell2,000$5.37597.95view
LINDER GREG WDirector 2013-02-19Sell1,314$34.767.83view
ASHLEY RICHARD WExecutive Vice President 2013-02-19Sell4,672$34.797.73view
Blaser Brian JExecutive Vice President 2013-02-19Sell1,022$34.797.73view
Landgraf John CExecutive Vice President 2013-02-19Sell3,066$34.787.76view
Fussell Stephen RSenior Vice President 2013-02-19Sell3,066$34.87.7view
Mason Heather LSenior Vice President 2013-02-19Sell3,066$34.797.73view
Simhambhatla Murthy VSenior Vice President 2013-02-19Sell402$34.787.76view
Warmuth Michael JExecutive Vice President 2013-02-19Sell3,066$34.787.76view
Fussell Stephen RSenior Vice President 2013-02-01Sell9,690$33.8910.59view

Press Releases about ABT:

Quarterly/Annual Reports about ABT:

News about abt:

Articles On GuruFocus.com
Guru Stocks at 52-Week Highs Apr 15 2013 
14 Cheapest Dividend-Paying Large Caps As of March 2013 Mar 23 2013 
Weekly 52 Week Highs: ABBV, ABT, YUM, AET Feb 11 2013 
Should dividend investors hold on to Abbott and Abbvie following the split? Feb 01 2013 
Reconsidering Abbott Labs (ABT) And AbbVie (ABBV) Jan 18 2013 
Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012 
Abbott Laboratories (ABT) Dividend Stock Analysis Dec 27 2012 
9 High-Yielding Mega-Cap Stocks Dec 26 2012 
Abbott Laboratories: Quality Dividend Aristocrat for Long Term Dividends Dec 21 2012 
Dividend Stocks I Purchased Over the Past Two Months Dec 19 2012 

More From Our Partners
CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog May 22 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK